BioMed Commercialization Center
2F., No.8, Sec.2, Sheng Yi Rd., Zhubei City, Hsinchu County 30261, Taiwan
About us
The BioMed Commercialization Center is dedicated to translating high-quality academia research into products of great clinical value. Our Medtech team provides companies one-stop support to accelerate through hurdles in commercialization and maximize global value. We provide startup support in value-adding (technology/IP/clinical), prototyping and commercialization. We are setup as a trusted partner for academic and industry clients’ entry into Taiwan’s fast-growing medtech sectors.
The BioMed Commercialization Center is dedicated to translating high-quality academia research into products of great clinical value. Our Medtech team provides companies one-stop support to accelerate through hurdles in commercialization and maximize global value. We provide startup support in value-adding (technology/IP/clinical), prototyping and commercialization. We are setup as a trusted partner for academic and industry clients’ entry into Taiwan’s fast-growing medtech sectors.
Products
Cranial burr hole cover of 3D bioceramic bone graft substitute
- A burr hole procedure in brain surgery allows further medical procedures to be performed including brain pressure reduction and removal of blood clots and tumors. The site of burr hole with bone damage must then be covered and fixated by a burr cap. Unfortunately current burr cap interferes with medical imaging, cannot be replaced by autologous bone and can induce autoimmune infection, leading to clinical issues including poor osseointegration and poor post-surgery follow-up.
- Our team developed a 3D printed bio-ceramic burr cover with an interconnected bionic bone structure that is uniquely biodegradable, such that when implanted can provide mechanical support fixation, and with time be biodegraded to be replaced with autologous bone, supporting a best clinical practice of osseointegration.
- Provides a burr hole cover that is with biomechanical strength and supports osseointegration. Will continue to demonstrate greater clinical value by developing products for large bone defect.
High-frequency ultrasonic anesthesia needle transducer
- Minimally invasive surgery is rapidly advancing with particular interest in neural block procedures, including paravertebral block (abbreviated PVB). Current PVB is performed using surface ultrasound imaging to guide needle insertion dorsally to the spine into an intercostal space for anesthetic injection. However there are limitations in this method: the large angle between the surface ultrasound probe and the needle head, the greater depth in PVB insertion, can lead to unclear ultrasound image of the needle head undermining accurate needle positioning and can lead to difficulty in the anesthetic procedure, and can increase risks of pneumothorax or nerve injury.
- This team is developing a high frequency ultrasound probe which can be inserted as an micro-probe with the anesthesia needle to allow real-time display of the distance between the needle head and the pleura, providing puncture location assistance and warning system to support accurate anesthesia positioning.
- Increasing the safety and success rate of anesthesia puncture in the thoracic region, reduce procedural risks such as pleural injury and pneumothorax.
Precision Blood Test Kit for Screening for Breast Cancer
- Breast cancer tops the global incidence chart for female cancers. While mammography is the most common screening test for breast cancer, some 71% of its results are false positives. What this entails is undeniably a waste of medical resources.
- The team has thus developed a blood test kit to screen for breast cancer. Qualitative testing is done on cell-free DNA with a view to identifying DNA methylation that is specific to breast cancer. In addition to accuracy of up to 90%, this approach has the capacity for detecting breast cancer early on (stage 0, I, and II). Physicians can thus better help women of 20-80 determine if they have breast cancer.
- Complement mammography to enhance accuracy so that patients can secure precise diagnosis and proper treatment early on.